Estrella Immunopharma Inc stock is traded at $0.4101, with a volume of 163,054. It is down -7.53% in the last 24 hours and down -4.41% over the past month. Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Previous Close:
$0.4435
Open:
$0.444
24h Volume:
163,054
Relative Volume:
0.18
Market Cap:
$17.84M
Revenue:
-
Net Income/Loss:
-$13.25M
P/E Ratio:
-
EPS:
-$0.3533
Net Cash Flow:
-$8.02M
1W Performance:
-35.85%
1M Performance:
-4.41%
6M Performance:
-68.45%
1Y Performance:
-85.14%
1-Day Range:
$0.00$0.00
1-Week Range:
$0.3517$0.6393
52-Week Range:
$0.24$3.01
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Name
Estrella Immunopharma IncSector
HealthcareIndustry
BiotechnologyPhone
(510) 318-9098Address
5858 HORTON STREET, SUITE 370, EMERYVILLE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS